James Shin
Stock Analyst at Deutsche Bank
(0)
# 4796
Out of 5,240 analysts
19
Total ratings
0.00%
Success rate
-24.55%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Eli Lilly | Maintains: Buy | 1025 1015 | 752.59 | 34.87% | 4 | Nov 4, 2024 | |
Amgen | Reiterates: Hold | 310 305 | 270.74 | 12.65% | 2 | Aug 7, 2024 | |
Incyte | Maintains: Hold | 55 60 | 72.88 | -17.67% | 2 | Aug 1, 2024 | |
Bristol-Myers Squibb | Maintains: Hold | 53 45 | 56.27 | -20.03% | 2 | Jul 23, 2024 | |
Legend Biotech | Initiates Coverage On: Buy | 60 | 31.6 | 89.87% | 1 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 75 | 91.91 | -18.4% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 150 | 172.33 | -12.96% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 800 | 698.75 | 14.49% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 115 | 100.32 | 14.63% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 25 | n/a | n/a | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 2.28 | 338.6% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | 1.79 | 570.39% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 80 70 | 1.1 | 6263.64% | 1 | Dec 12, 2022 |